$1.62
-0.43-20.98%
At Close: -
$1.62
00.00%
After Hours: Sep 20, 4:10 PM EDT
15 minutes delayed
Comments
Loading...
PharmaCyte Biotech (PMCB) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPharmaCyte Biotech (NASDAQ:PMCB) Stock Quotes, Forecast and News Summary
PharmaCyte Biotech Stock (NASDAQ: PMCB) stock price, news, charts, stock research, profile.
| Open | $2.00 |
| Close | $1.62 |
| Volume / Avg. | 37.40K / 13.94K |
| Day Range | $1.51 - $2.00 |
| 52 Wk Range | 1.39 - 2.60 |
| Market Cap | $12.49M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 43 |
| Short Interest | 0.15% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About PharmaCyte Biotech Inc
Sector
Health Care
Industry
Biotechnology
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developi...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy PharmaCyte Biotech (PMCB) stock?
You can purchase shares of PharmaCyte Biotech (NASDAQ:PMCB) through any online brokerage.
Who are PharmaCyte Biotech (PMCB) competitors?
Other companies in PharmaCyte Biotech’s space includes: NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).
What is the forecast, or price target, for PharmaCyte Biotech (PMCB) stock?
There is no analysis for PharmaCyte Biotech to provide a consensus price target.
What is the current price for PharmaCyte Biotech (PMCB)?
The stock price for PharmaCyte Biotech (NASDAQ: PMCB) is $1.62 last updated September 20, 2024 at 4:10 PM EDT.
Does PharmaCyte Biotech (PMCB) pay a dividend?
There are no upcoming dividends for PharmaCyte Biotech.
When is PharmaCyte Biotech (NASDAQ:PMCB) reporting earnings?
PharmaCyte Biotech’s Q2 earnings are confirmed for Friday, December 13, 2024.
Is PharmaCyte Biotech (PMCB) going to split?
There is no upcoming split for PharmaCyte Biotech.
What sector and industry does PharmaCyte Biotech (PMCB) operate in?
PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.